EQUITY (Details) (USD $)	1 Months Ended	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Stockholders Equity Note [Line Items]
Capital stock authorized	305,000,000	305,000,000
Preferred stock, shares authorized	5,000,000	5,000,000		5,000,000
Common stock, shares authorized	300,000,000	300,000,000		300,000,000
Common stock, par value per share	$ 0.001	$ 0.001		$ 0.001
Preferred stock, par value per share	$ 0.01	$ 0.01		$ 0.01
Shares issued as reimbursement for advances and payments made on behalf of the Company	33,045
Value of shares issued as reimbursement for advances and payments made on behalf of the Company	$ 33,045
Share-based compensation		155,217	600
Equity Issuance Transaction One [Member]
Stockholders Equity Note [Line Items]
Options granted				10,000
Vesting period				1 year
Expected term				10 years
Exercise price				$ 0.10
Grant date fair value				74,313
Share-based compensation		16,865
Unrecognized compensation cost	9,366	9,366
Equity Issuance Transaction One [Member] | Minimum [Member]
Stockholders Equity Note [Line Items]
Stock price				$ 0.10
Risk-free interest rate				2.47%
Expected volatility				157.00%
Equity Issuance Transaction One [Member] | Maximum [Member]
Stockholders Equity Note [Line Items]
Options granted				70,000
Stock price				$ 2.15
Risk-free interest rate				3.00%
Expected volatility				159.00%
Equity Issuance Transaction Two [Member]
Stockholders Equity Note [Line Items]
Options granted				259,706
Vesting period				1 year
Expected term				10 years
Exercise price				$ 0.43
Stock price				$ 1.50
Risk-free interest rate				2.17%
Expected volatility				156.00%
Grant date fair value				386,724
Share-based compensation		96,681
Unrecognized compensation cost	$ 290,043	$ 290,043
Options vested		64,927